EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale

Gianni Pastore iD, Matteo Bertini iD, Carlo Bonanno, Giovanni Coluccia iD, Gabriele Dell'Era iD, Luca De Mattia iD, Domenico Grieco iD, Grigorius Katsouras iD, Massimiliano Maines, Lina Marcantoni iD, Leonardo Marinaccio iD, Gabriele Paglino und 4 weitere

Europace · 2023

DOI: 10.1093/europace/euad082 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Europace, 2023. Verfasst von Gianni Pastore und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology, Santa Maria della Misericordia Hospital, Via Tre Martiri 140, 45100 Rovigo, Italy. Hauptthemen laut MEDLINE: Atrial Fibrillation, Pacemaker, Artificial, Atrioventricular Block. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 22 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: QUOVADIS, Boston Scientific International SA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aims

In patients with prolonged atrioventricular (AV) conduction and pacemaker (PM) indication due to sinus node disease (SND) or intermittent AV-block who do not need continuous ventricular pacing (VP), it may be difficult to determine which strategy to adopt. Currently, the standard of care is to minimize unnecessary VP by specific VP avoidance (VPA) algorithms. The superiority of this strategy over standard DDD or DDD rate-responsive (DDD/DDDR) in improving clinical outcomes is controversial, probably owing to the prolongation of the atrialventricular conduction (PR interval) caused by the algorithms. Conduction system pacing (CSP) may offer the most physiological-VP approach, providing appropriate AV conduction and preventing pacing-induced dyssynchrony. Methods and results PhysioVP-AF is a prospective, controlled, randomized, single-blind trial designed to determine whether atrial-synchronized conduction system pacing (DDD-CSP) is superior to standard DDD-VPA pacing in terms of 3-year reduction of persistent-AF occurrence. Cardiovascular hospitalization, quality-of-life, and safety will be evaluated. Patients with indication for permanent DDD pacing for SND or intermittent AV-block and prolonged AV conduction (PR interval > 180 ms) will be randomized (1:1 ratio) to DDD-VPA (VPA-algorithms ON, septal/apex position) or to DDD-CSP (His bundle or left bundle branch area pacing, AV-delay setting to control PR interval, VPA-algorithms OFF). Approximately 400 patients will be randomized in 24 months in 13 Italian centres.

Conclusion

The PhysioVP-AF study will provide an essential contribution to patient management with prolonged AV conduction and PM indication for sinus nodal disease or paroxysmal 2nd-degree AV-block by determining whether CSP combined with a controlled PR interval is superior to standard management that minimizes unnecessary VP in terms of reducing clinical outcomes.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FibrillationPacemaker, ArtificialAtrioventricular BlockHumansCardiac Pacing, ArtificialProspective StudiesSingle-Blind MethodSick Sinus SyndromeRandomized Controlled Trials as Topic

Stichwörter der Autor:innen

Atrial fibrillationHis bundle pacingLeft bundle branch area pacingManaged ventricular pacingVentricular pacing avoidance

Autor:innen und Institutionen

  • Department of Cardiology, Santa Maria della Misericordia Hospital, Via Tre Martiri 140, 45100 Rovigo, Italy.
  • Department of Cardiology, University Hospital, via Aldo Moro, n 8, 44124 Ferrara, Italy.
  • Department of Cardiology, San Bortolo Hospital, Viale Rodolfi 37, 36100 Vicenza, Italy.
  • Department of Cardiology, C. G. Panico Hospital, via San Pio X 4, 73039 LecceItaly.
  • Department of Cardiology, Maggiore della Carità Hospital, corso Mazzini 18, 28100 Novara, Italy.
  • Department of Cardiology, Ca' Foncello Hospital, Piazzale Ospedale 1, 31100 Treviso, Italy.

ORCID-Profile: Gianni Pastore, Matteo Bertini, Giovanni Coluccia, Gabriele Dell'Era, Luca De Mattia, Domenico Grieco, Grigorius Katsouras, Lina Marcantoni, Leonardo Marinaccio, Pietro Palmisano, Matteo Ziacchi, Franco Zoppo, Franco Noventa

Förderung

  • QUOVADIS
  • Boston Scientific International SA

Zitieren

APA

Pastore, G., Bertini, M., Bonanno, C., Coluccia, G., Dell'Era, G., De Mattia, L., Grieco, D., Katsouras, G., Maines, M., Marcantoni, L., Marinaccio, L., Paglino, G., Palmisano, P., Ziacchi, M., Zoppo, F., & Noventa, F. (2023). The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale. Europace. https://doi.org/10.1093/europace/euad082

Vancouver

Pastore G, Bertini M, Bonanno C, Coluccia G, Dell'Era G, De Mattia L, et al. The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale. Europace. 2023. doi:10.1093/europace/euad082

BibTeX
@article{Pastore2023,
  author = {Pastore, Gianni and Bertini, Matteo and Bonanno, Carlo and Coluccia, Giovanni and Dell'Era, Gabriele and De Mattia, Luca and Grieco, Domenico and Katsouras, Grigorius and Maines, Massimiliano and Marcantoni, Lina and Marinaccio, Leonardo and Paglino, Gabriele and Palmisano, Pietro and Ziacchi, Matteo and Zoppo, Franco and Noventa, Franco},
  title = {The PhysioVP-AF study, a randomized controlled trial to assess the clinical benefit of physiological ventricular pacing vs. managed ventricular pacing for persistent atrial fibrillation prevention in patients with prolonged atrioventricular conduction: design and rationale},
  journal = {Europace},
  year = {2023},
  doi = {10.1093/europace/euad082}
}
Kostenlos starten →